CMH :: Clinical and Molecular Hepatology

5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside Attenuates High Fat, High Fructose Diet-induced Fatty Liver and Fibrosis in Mice.

Biomedical and Pharmacology Journal.2024; 17(1): 383. CrossRef

Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective

Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin

David Travis Thomas, Nicholas R. DelCimmuto, Kyle D. Flack, David E. Stec, Terry D. Hinds

Klinik Laboratuvarda Gereksiz Testleri Önleme Yöntemi

Ataman GÖNEL, İsmail KOYUNCU, Nihayet BAYRAKTAR, Murat ÇAĞLAYAN

Harran Üniversitesi Tıp Fakültesi Dergisi.2022; 19(1): 164. CrossRef

Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways

Olufunto O. Badmus, Sarah A. Hillhouse, Christopher D. Anderson, Terry D. Hinds, David E. Stec

Bilirubin as a metabolic hormone: the physiological relevance of low levels

Justin F. Creeden, Darren M. Gordon, David E. Stec, Terry D. Hinds

American Journal of Physiology-Endocrinology and Metabolism.2021; 320(2): E191. CrossRef

Porphyran‐derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice

Xueliang Wang, Di Liu, Zhe Wang, Chao Cai, Hao Jiang, Guangli Yu

Clinical biochemistry test eliminator providing cost-effectiveness with five algorithms

Heme-Derived Metabolic Signals Dictate Immune Responses

Giacomo Canesin, Seyed M. Hejazi, Kenneth D. Swanson, Barbara Wegiel

Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator–activated receptor α

Darren M. Gordon, Kari L. Neifer, Abdul-Rizaq Ali Hamoud, Charles F. Hawk, Andrea L. Nestor-Kalinoski, Scott A. Miruzzi, Michael P. Morran, Samuel O. Adeosun, Jeffrey G. Sarver, Paul W. Erhardt, Robert E. McCullumsmith, David E. Stec, Terry D. Hinds

Journal of Biological Chemistry.2020; 295(29): 9804. CrossRef

Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1

Terry D. Hinds, Justin F. Creeden, Darren M. Gordon, Adam C. Spegele, Steven L. Britton, Lauren G. Koch, David E. Stec

The Role of Bilirubin and the Other “Yellow Players” in Neurodegenerative Diseases

Sri Jayanti, Libor Vítek, Claudio Tiribelli, Silvia Gazzin

Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity

Valentina Ceccarelli, Ilaria Barchetta, Flavia Agata Cimini, Laura Bertoccini, Caterina Chiappetta, Danila Capoccia, Raffaella Carletti, Claudio Di Cristofano, Gianfranco Silecchia, Mario Fontana, Frida Leonetti, Andrea Lenzi, Marco Giorgio Baroni, Eugeni

International Journal of Molecular Sciences.2020; 21(23): 9091. CrossRef

Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate

Terry D. Hinds, Justin F. Creeden, Darren M. Gordon, Donald F. Stec, Matthew C. Donald, David E. Stec

Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity

Flavia Agata Cimini, Andrea Arena, Ilaria Barchetta, Antonella Tramutola, Valentina Ceccarelli, Chiara Lanzillotta, Mario Fontana, Laura Bertoccini, Frida Leonetti, Danila Capoccia, Gianfranco Silecchia, Claudio Di Cristofano, Caterina Chiappetta, Fabio D

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2019; 1865(6): 1490. CrossRef

CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation

Darren M. Gordon, Samuel O. Adeosun, Somtochukwu I. Ngwudike, Christopher D. Anderson, John E. Hall, Terry D. Hinds, David E. Stec

Archives of Biochemistry and Biophysics.2019; 672: 108072. CrossRef

Effect of Cys34 Oxidation State of Albumin on Its Interaction with Paraoxon according to Molecular Modeling Data

D. A. Belinskaia, M. A. Terpilovskii, A. A. Batalova, N. V. Goncharov

Russian Journal of Bioorganic Chemistry.2019; 45(6): 535. CrossRef

Abdul-Rizaq Hamoud, Lauren Weaver, David E. Stec, Terry D. Hinds

Trends in Endocrinology & Metabolism.2018; 29(3): 140. CrossRef

Biliverdin reductase and bilirubin in hepatic disease

Lauren Weaver, Abdul-rizaq Hamoud, David E. Stec, Terry D. Hinds

American Journal of Physiology-Gastrointestinal and Liver Physiology.2018; 314(6): G668. CrossRef

Bilirubin, a new therapeutic for kidney transplant?

Vikram L. Sundararaghavan, Sivjot Binepal, David E. Stec, Puneet Sindhwani, Terry D. Hinds

Transplantation Reviews.2018; 32(4): 234. CrossRef

Association of serum total bilirubin and plasma 8-OHdG in HIV/AIDS patients

Interventional Medicine and Applied Science.2018; 10(2): 76. CrossRef

Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?

Terry D. Hinds, Samuel O. Adeosun, Abdulhadi A. Alamodi, David E. Stec

Bilirubin Binding to PPARα Inhibits Lipid Accumulation

David E. Stec, Kezia John, Christopher J. Trabbic, Amarjit Luniwal, Michael W. Hankins, Justin Baum, Terry D. Hinds, Hervé Guillou

Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α

Terry D. Hinds, Katherine A. Burns, Peter A. Hosick, Lucien McBeth, Andrea Nestor-Kalinoski, Heather A. Drummond, Abdulhadi A. AlAmodi, Michael W. Hankins, John P. Vanden Heuvel, David E. Stec

Journal of Biological Chemistry.2016; 291(48): 25179. CrossRef

Systematic review: Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?

World Journal of Pharmacology.2014; 3(4): 209. CrossRef